Thomas Cordeiro, R.Ph. FASCP - President, is a pharmacist and executive who has been advising employers and health plan companies for over 20 years on how best to manage the cost of drug benefits without compromising health, safety and quality of care.
His experience includes working within a variety of business sectors, including commercial employers, purchasing coalitions, universities, public sector groups, Taft-Hartley funds, unions, and health plans.
Prior to founding Integrity Pharmaceutical Advisors, Thomas served as vice president of pharmacy practice at Aon Consulting, managing consultant at Cambridge Advisory Group and director of clinical services at Medco Health Solutions, Inc. His work experience included national practice leadership, clinical account management, and clinical education.
Thomas has authored numerous accredited educational publications for physicians and pharmacists. Topics include disease management, optimal therapeutic outcomes, and generic drugs. He was featured speaker at the Boston University School of Medicine’s “Geriatric Conference Series,” and has presented nationally on various other clinical topics. Other achievements include pioneering programs in “counter-detailing” the pharmaceutical industry while working with the Harvard Medical School’s Division on Aging.
He gained notoriety at Medco Health where he successfully launched the first national generic drug sampling program in the United States as well as leading the first PBM (Pharmacy Benefit Manager) to become accredited by the Accrediting Council for Continuing Medical Education.
Mark is a senior human resources executive who specializes in benefits administration and in leading organizations to innovative data driven solutions. Mark manages our professional teams that are engaged to evaluate and restructure health, welfare, and retirement benefit offerings.
Mark recently managed the analytical, actuarial, and implementation teams for the California Education Coalition for Health Care Reform’s statewide effort to improve quality and reduce the cost of healthcare to school districts throughout California. Under his direction, this CECHCR program has resulted in an average savings of more than $118 million for nine pilot school districts in California, of which more than $30 million was due to RX improvement.
In addition to more traditional benefit admin/actuarial project management consulting responsibilities, Mark has served as onsite interim management at the VP and human resources director levels for a variety of Fortune 500 and large, public sector clients.
Michelle serves as an expert resource for clinical formulary and prior authorization management. She is personally and professionally dedicated to assisting clients to achieve optimal formulary management efficiencies without compromising health, safety, and quality of care.
Michelle has served as the associate chief of clinical pharmacy programs at the VAMC and the clinical pharmacy coordinator at Bethesda North Hospital in Cincinnati, Ohio.
She has also served as the clinical pharmacy coordinator at Saints Mary & Elizabeth Hospital in Louisville, Kentucky.
During her tenure at these hospitals, she initiated clinical pharmacy services and training of staff pharmacists to improve a variety of patient safety issues, including: prospective and concurrent drug utilization evaluations, pharmacokinetic dosing, age-based hypnotic dosage adjustments, drug interaction monitoring alerts, intravenous-to-oral therapy transitions, optimizing anti-infective therapies, and patient interview programs.
Michelle served as adjunct assistant professor of clinical pharmacy at Ohio Northern University and at the University of Cincinnati, and was also continuing education provider for the Ohio Board of Pharmacy. She has also served on several pharmacy and therapeutic committees and on the VAMC Formulary Council.
She has worked in conjunction with large commercial and public sector employers, physicians, patients, hospitals, universities, and health plans.
Jerry leads our technical team in data management, security, and is the co-creator of our propriety audit, data analytical, and financial modeling systems.
Jerry has most recently worked as Director of Actuarial Analytics and Strategic Initiatives for a major insurance carrier. His previous experience includes roles at an employee benefit consulting firm where he primarily served larger employer and fortune 500 groups and has had progressive actuarial and management responsibilities for several Blue Cross plans.
While Jerry’s expertise extends across a wide range of health care and actuarial subjects, his professional interests of developing creative solutions to optimize plan performance and improve member health has lead him to specialize in Pharmaceutical analytics.